Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | dihydroergotamine | 10531 | drug-path |
Asthma | R-HSA-444620 | map05310 | dihydroergotamine | 10531 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | dihydroergotamine | 10531 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | dihydroergotamine | 10531 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | dihydroergotamine | 10531 | drug-path |
Circadian rhythm - mammal | R-HSA-400253 | 0 | dihydroergotamine | 10531 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | acenocoumarol | 54676537 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | acenocoumarol | 54676537 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | acenocoumarol | 54676537 | drug-path |
Apoptosis | R-HSA-109581 | map04210 | acenocoumarol | 54676537 | drug-path |
RNA polymerase | R-HSA-73864 | map03020 | acenocoumarol | 54676537 | drug-path |
Colorectal cancer | R-HSA-4791275 | map05210 | acenocoumarol | 54676537 | drug-path |
Renal cell carcinoma | R-HSA-9794523 | map05211 | triamcinolone | 31307 | drug-path |
Pathways in cancer | R-HSA-9824443 | map05200 | triamcinolone | 31307 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | triamcinolone | 31307 | drug-path |
Focal adhesion | R-HSA-354113 | map04510 | triamcinolone | 31307 | drug-path |
Acute myeloid leukemia | R-HSA-9680350 | map05221 | triamcinolone | 31307 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | triamcinolone | 31307 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | dihydrostreptomycin | 3229 | drug-path |
Gap junction | R-HSA-190861 | map04540 | dihydrostreptomycin | 3229 | drug-path |